Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate

Documenti analoghi

• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
  di: Clerico, M, et al.
  Pubblicazione: (2008)
• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
  di: Clerico, M, et al.
  Pubblicazione: (2008)
• Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
  di: Clerico, M, et al.
  Pubblicazione: (2006)
• Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
  di: Clerico, M, et al.
  Pubblicazione: (2008)
• Conversion from clinically isolated syndromes to multiple sclerosis: how could we prevent it? A Cochrane review of published trials
  di: Clerico, M, et al.
  Pubblicazione: (2007)